COBENFY (XANOMELINE-TROSPIUM CHLORIDE) AS A BREAKTHROUGH IN SCHIZOPHRENIA TREATMENT: POTENTIAL IMPACT ON PATIENT QUALITY OF LIFE AND HEALTHCARE ECONOMICS. IJITSS [Internet]. 2026 Jan. 17 [cited 2026 Mar. 17];1(1(49). Available from: https://rspublisher.org/index.php/ijitss/article/view/4695